Which type of vascular access device is specifically designed for chemotherapy administration?

The choice indicating that both central venous catheters and implantable ports are specifically designed for chemotherapy administration is accurate because both types of vascular access devices are commonly utilized to safely administer chemotherapy medications.

Central venous catheters (CVCs) provide a reliable way to deliver chemotherapy into larger veins directly. They can remain in place for extended periods, which is essential for patients needing prolonged treatment. Since many chemotherapy agents are highly caustic, CVCs help to reduce the risk of complications, such as phlebitis and tissue damage, associated with peripheral access.

Implantable ports, on the other hand, are specifically designed for long-term access and are often used in patients who may require repeated chemotherapy treatments over weeks or months. The port is implanted under the skin, offering several advantages: it is less noticeable, reduces the risk of infection, and allows for quick access when infusions are needed, while minimizing discomfort for the patient.

Both devices facilitate the administration of chemotherapy in a manner that promotes patient safety and comfort, making them instrumental in oncology care.